NCT06179706View on ClinicalTrials.gov

11C-choline PET/CT Based Helical Tomotherapy as Innovative Treratment Approach for Bone Metastases in Prostate Cancer Patients.

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

October 27, 2015

Primary Completion Date

November 25, 2015

Study Completion Date

November 25, 2015

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

11C-choline PET/CT

In our study we evaluated the efficacy of high-dose RT guided by 11C-Choline PET/CT on bone metastases in prostate cancer patients with a limited number of metastases.

Trial Locations (1)

Unknown

Irccs San Raffaele, Milan

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER

NCT06179706 - 11C-choline PET/CT Based Helical Tomotherapy as Innovative Treratment Approach for Bone Metastases in Prostate Cancer Patients. | Biotech Hunter | Biotech Hunter